← Back to Alzheimer's Drug Discovery Foundation Profile
The average check size of Alzheimer's Drug Discovery Foundation is $500,000–$3,000,000 USD.
The Alzheimer's Drug Discovery Foundation (ADDF) is a venture philanthropy organization dedicated to funding breakthrough research in academia and the biotech industry to find drugs for Alzheimer's disease. Founded in 1998 by Leonard A. and Ronald S. Lauder, the ADDF has awarded nearly $400 million to fund 792 Alzheimer's drug development, biomarker, and prevention programs in 21 countries.
The Alzheimer's Drug Discovery Foundation (ADDF) is a venture philanthropy organization dedicated to funding breakthrough research in academia and the biotech industry to find drugs for Alzheimer's disease.
The Alzheimer's Drug Discovery Foundation is located in New York, USA.
The founding date of Alzheimer's Drug Discovery Foundation is not publicly available.
Alzheimer's Drug Discovery Foundation is a venture capital firm.
Yes, Alzheimer's Drug Discovery Foundation invests in Biotechnology.
Yes, Alzheimer's Drug Discovery Foundation invests in Pharmaceuticals.
Verification Confidence: 90% | Source: portfolio | Entity: Alzheimer's Drug Discovery Foundation